A 12 week, multi-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of SKBE on atopic dermatitis in childre

Not Applicable

Recruiting

• Conditions: Diseases of the skin and subcutaneous tissue

• Registration Number: KCT0003259
• Lead Sponsor: ifetree Biotech

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 March 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

1) Subjects who agree the particpation in the trial and submit informed and consent before the beginning of the trial.
2) subjects over 2 years and under 12 years of age inclusive
3) Subjects scored 20~50 from SCORing of Atopic Dermatitis

Exclusion Criteria

1) The patient who take the medicine that can affect the state of Atopic Dermatitis within recent 1 week.
2) Subjects which in the opinion investigator could affect preclude evluation of response

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
SCORing of Atopic Dermatitis total score

Secondary Outcome Measures

Name	Time	Method
SCORing of Atopic Dermatitis objective score;SCORing of Atopic Dermatitis subjective score